vs

Side-by-side financial comparison of Cellebrite DI Ltd. (CLBT) and Ingevity Corp (NGVT). Click either name above to swap in a different company.

Cellebrite DI Ltd. is the larger business by last-quarter revenue ($292.2M vs $185.4M, roughly 1.6× Ingevity Corp). Ingevity Corp runs the higher net margin — -45.6% vs -103.5%, a 57.8% gap on every dollar of revenue. Ingevity Corp produced more free cash flow last quarter ($73.5M vs $60.8M). Over the past eight quarters, Cellebrite DI Ltd.'s revenue compounded faster (72.8% CAGR vs -26.2%).

Cellebrite DI Ltd. is a digital forensics company headquartered in Petah Tikva, Israel that provides tools for law enforcement agencies as well as enterprise companies and service providers to collect, review, analyze and manage digital data. Their flagship product series is the Cellebrite UFED.

Ingevity Corp is a global specialty chemicals and advanced materials manufacturer. It produces high-performance carbon materials, pavement preservation solutions, and specialty chemicals, serving automotive emissions control, industrial purification, road infrastructure, and agricultural input markets across North America, Europe, and Asia Pacific.

CLBT vs NGVT — Head-to-Head

Bigger by revenue
CLBT
CLBT
1.6× larger
CLBT
$292.2M
$185.4M
NGVT
Higher net margin
NGVT
NGVT
57.8% more per $
NGVT
-45.6%
-103.5%
CLBT
More free cash flow
NGVT
NGVT
$12.7M more FCF
NGVT
$73.5M
$60.8M
CLBT
Faster 2-yr revenue CAGR
CLBT
CLBT
Annualised
CLBT
72.8%
-26.2%
NGVT

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
CLBT
CLBT
NGVT
NGVT
Revenue
$292.2M
$185.4M
Net Profit
$-302.3M
$-84.6M
Gross Margin
84.6%
41.2%
Operating Margin
14.1%
-47.7%
Net Margin
-103.5%
-45.6%
Revenue YoY
36.7%
Net Profit YoY
-609.6%
EPS (diluted)
$-1.50
$-2.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLBT
CLBT
NGVT
NGVT
Q4 25
$185.4M
Q3 25
$292.2M
$333.1M
Q2 25
$220.8M
$365.1M
Q1 25
$89.6M
$284.0M
Q4 24
$135.6M
Q3 24
$232.1M
$333.8M
Q2 24
$185.3M
$390.6M
Q1 24
$71.2M
$340.1M
Net Profit
CLBT
CLBT
NGVT
NGVT
Q4 25
$-84.6M
Q3 25
$-302.3M
$43.5M
Q2 25
$36.9M
$-146.5M
Q1 25
$-71.4M
$20.5M
Q4 24
$16.6M
Q3 24
$-107.2M
Q2 24
$-95.2M
$-283.7M
Q1 24
$-40.6M
$-56.0M
Gross Margin
CLBT
CLBT
NGVT
NGVT
Q4 25
41.2%
Q3 25
84.6%
40.2%
Q2 25
84.1%
37.8%
Q1 25
85.2%
39.9%
Q4 24
81.3%
Q3 24
83.5%
39.4%
Q2 24
84.1%
31.5%
Q1 24
82.6%
29.3%
Operating Margin
CLBT
CLBT
NGVT
NGVT
Q4 25
-47.7%
Q3 25
14.1%
18.7%
Q2 25
12.1%
-39.1%
Q1 25
10.3%
9.4%
Q4 24
Q3 24
7.9%
33.0%
Q2 24
11.7%
25.9%
Q1 24
0.2%
22.6%
Net Margin
CLBT
CLBT
NGVT
NGVT
Q4 25
-45.6%
Q3 25
-103.5%
13.1%
Q2 25
16.7%
-40.1%
Q1 25
-79.7%
7.2%
Q4 24
12.2%
Q3 24
-32.1%
Q2 24
-51.4%
-72.6%
Q1 24
-57.0%
-16.5%
EPS (diluted)
CLBT
CLBT
NGVT
NGVT
Q4 25
$-2.33
Q3 25
$-1.50
$1.18
Q2 25
$0.15
$-4.02
Q1 25
$-0.36
$0.56
Q4 24
$0.44
Q3 24
$-0.35
$-2.94
Q2 24
$-0.48
$-7.81
Q1 24
$-0.21
$-1.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLBT
CLBT
NGVT
NGVT
Cash + ST InvestmentsLiquidity on hand
$191.7M
$78.1M
Total DebtLower is stronger
$1.2B
Stockholders' EquityBook value
$336.0M
$29.7M
Total Assets
$690.6M
$1.7B
Debt / EquityLower = less leverage
39.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLBT
CLBT
NGVT
NGVT
Q4 25
$78.1M
Q3 25
$191.7M
$83.4M
Q2 25
$326.1M
$76.9M
Q1 25
$191.7M
$71.5M
Q4 24
$68.0M
Q3 24
$189.5M
$135.5M
Q2 24
$178.6M
$107.4M
Q1 24
$189.5M
$88.5M
Total Debt
CLBT
CLBT
NGVT
NGVT
Q4 25
$1.2B
Q3 25
$1.2B
Q2 25
$1.2B
Q1 25
$1.3B
Q4 24
$1.3B
Q3 24
$1.4B
Q2 24
$1.4B
Q1 24
$1.4B
Stockholders' Equity
CLBT
CLBT
NGVT
NGVT
Q4 25
$29.7M
Q3 25
$336.0M
$138.1M
Q2 25
$408.4M
$120.7M
Q1 25
$336.0M
$234.6M
Q4 24
$195.2M
Q3 24
$34.2M
$214.5M
Q2 24
$-40.2M
$284.8M
Q1 24
$34.2M
$568.2M
Total Assets
CLBT
CLBT
NGVT
NGVT
Q4 25
$1.7B
Q3 25
$690.6M
$1.8B
Q2 25
$787.4M
$1.9B
Q1 25
$690.6M
$2.1B
Q4 24
$2.0B
Q3 24
$532.9M
$2.2B
Q2 24
$556.6M
$2.3B
Q1 24
$532.9M
$2.6B
Debt / Equity
CLBT
CLBT
NGVT
NGVT
Q4 25
39.10×
Q3 25
8.39×
Q2 25
10.24×
Q1 25
5.68×
Q4 24
6.86×
Q3 24
6.52×
Q2 24
4.92×
Q1 24
2.48×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLBT
CLBT
NGVT
NGVT
Operating Cash FlowLast quarter
$66.2M
$97.1M
Free Cash FlowOCF − Capex
$60.8M
$73.5M
FCF MarginFCF / Revenue
20.8%
39.6%
Capex IntensityCapex / Revenue
1.8%
12.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$172.1M
$273.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLBT
CLBT
NGVT
NGVT
Q4 25
$97.1M
Q3 25
$66.2M
$129.7M
Q2 25
$53.5M
$79.0M
Q1 25
$10.0M
$25.4M
Q4 24
$64.5M
Q3 24
$58.2M
$46.5M
Q2 24
$24.6M
$29.7M
Q1 24
$12.5M
$-12.1M
Free Cash Flow
CLBT
CLBT
NGVT
NGVT
Q4 25
$73.5M
Q3 25
$60.8M
$117.8M
Q2 25
$47.5M
$66.8M
Q1 25
$8.5M
$15.4M
Q4 24
$39.6M
Q3 24
$55.3M
$28.5M
Q2 24
$21.0M
$11.6M
Q1 24
$11.4M
$-28.7M
FCF Margin
CLBT
CLBT
NGVT
NGVT
Q4 25
39.6%
Q3 25
20.8%
35.4%
Q2 25
21.5%
18.3%
Q1 25
9.5%
5.4%
Q4 24
29.2%
Q3 24
23.8%
8.5%
Q2 24
11.3%
3.0%
Q1 24
16.0%
-8.4%
Capex Intensity
CLBT
CLBT
NGVT
NGVT
Q4 25
12.7%
Q3 25
1.8%
3.6%
Q2 25
2.7%
3.3%
Q1 25
1.7%
3.5%
Q4 24
18.4%
Q3 24
1.3%
5.4%
Q2 24
1.9%
4.6%
Q1 24
1.5%
4.9%
Cash Conversion
CLBT
CLBT
NGVT
NGVT
Q4 25
Q3 25
2.98×
Q2 25
1.45×
Q1 25
1.24×
Q4 24
3.89×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLBT
CLBT

Subscription services$197.2M67%
Term-license$60.8M21%
Professional services$23.2M8%
Other non-recurring$11.0M4%

NGVT
NGVT

Performance Materials$151.2M82%
Advanced Polymer Technologies Segment$36.5M20%

Related Comparisons